Clicky

China Medical Sys Hlds(CHSYF)

Description: China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products to hospital and medical institutions in the People's Republic of China. It offers products under the direct and agency networks. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for the treatment of blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise Tanshinone capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu, for treating respiratory diseases; Ganfule capsules for the treatment of primary carcinoma of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for bone pains; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. It also engages in the agriculture business. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.


Keywords: Pharmaceutical Products Clinical Medicine Infection Hypertension Hepatitis Hepatitis B Depression Respiratory Diseases Ulcerative Colitis Heart Failure Liver Disease Crohn's Disease Diarrhea Ulcer Heart Disease Carcinoma Cholesterol Colitis Constipation Angina Coronary Artery Disease Flux Sterol Anxiety Myocardial Infarction Treatment Of Hypertension Hepatitis A Rcti Gastritis Ngg Angina Pectoris Fungal Infection Fungal Infections Chronic Heart Failure Chronic Hepatitis B Asos Coronary Heart Disease Chronic Constipation Mastitis Pains Acute Heart Failure Infarction Pepsi Asthenopia Eye Drop Treatment Of Diarrhea Biliary Reflux Gastritis Carbuncle Cellulitis Cholestatic Liver Disease Cholesterol Gallstones Lamisil Mixed Angina Otitis Stable Angina Pectoris Superficial Phlebitis Tonsillitis Treatment Of Acute Heart Failure Treatment Of Coronary Heart Disease Acute Hepatitis A Boils Illit Osteomyelitis Otitis Externa Parlodel Protein Hydrolysate Oral Solution Traumatic Infection

Home Page: web.cms.net.cn/zh/home/

Island Place Tower
North Point,
Hong Kong
Phone: 852 2369 7678


Officers

Name Title
Mr. Kong Lam Founder, Chairman, CEO & President
Ms. Yanling Chen CFO, VP & Executive Director
Mr. Hongbing Chen COO, VP, Director of Sales & Marketing and Executive Director
Ms. Sanyan Wu Director of Legal Department & Company Secretary
Dr. Huaizheng Peng M.D., Ph.D. Chief Business Officer
Mr. Fei Jiang Chief Investment Officer of Greater China
Mr. James Patrick Stearns Chief Investment Officer of Europe & America

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 7.9428
Trailing PE: 6.6479
Price-to-Book MRQ: 1.0608
Price-to-Sales TTM: 0.3237
IPO Date:
Fiscal Year End: December
Full Time Employees: 5701
Back to stocks